News
USNA
44.49
-3.20%
-1.47
USNA Stock Earnings: Usana Health Sciences Misses EPS, Misses Revenue for Q2 2024
Usana Health Sciences reported earnings per share of 54 cents for the second quarter of 2024. The company reported revenue of $212.87 million. This was 3.67% lower than the analyst estimate for the same period. Usana health Sciences reported results for the third quarter of 2016.
Investorplace · 1d ago
USANA Health Sciences Shares Fall 6.4% After Cut to 2024 Sales, EPS Guidance
Dow Jones · 1d ago
USANA Health Sciences (USNA) Misses Q2 Earnings and Revenue Estimates
NASDAQ · 1d ago
USANA Health Sciences GAAP EPS of $0.54 misses by $0.11, revenue of $212.87M misses by $8.1M
USANA Health Sciences reports Q2 GAAP EPS of $0.54, revenue of $212.87M misses by $8.1M. Company updates fiscal year 2024 net sales and diluted EPS outlook to $850 million to $880 million. Shares -7.42%.
Seeking Alpha · 1d ago
Usana Health Sciences Q2 2024 GAAP EPS $0.54 Misses $0.65 Estimate, Sales $212.869M Miss $221.032M Estimate
Usana Health Sciences reported quarterly earnings of $0.54 per share. The company reported quarterly sales of $212.869 million which missed the analyst consensus estimate of $221.032 million. Usana also reported a 10.64 percent decrease in sales from the same period last year.
Benzinga · 1d ago
*USANA Health Sciences: 2Q Operating Results Were Below Our Expectations >USNA
Dow Jones · 1d ago
*USANA Health Sciences Narrows FY24 View To EPS $2.40-EPS $2.55 >USNA
Dow Jones · 1d ago
*USANA Health Sciences Has Expectation for a Continued Challenging Operating Environment Across Many Markets
Dow Jones · 1d ago
*USANA Health Sciences Narrows FY24 View To Sales $850M-$880M >USNA
Dow Jones · 1d ago
Press Release: USANA Health Sciences Reports -3-
Dow Jones · 1d ago
*USANA Health Sciences 2Q Sales $212.9M >USNA
Dow Jones · 1d ago
*USANA Health Sciences 2Q EPS 54c >USNA
Dow Jones · 1d ago
Press Release: USANA Health Sciences Reports Second Quarter 2024 Results
Dow Jones · 1d ago
Press Release: USANA Health Sciences Reports -2-
Dow Jones · 1d ago
*USANA Health Sciences 2Q Net $10.4M >USNA
Dow Jones · 1d ago
USANA Health: Q2 Earnings Snapshot
USANA Health Sciences Inc. Reports earnings of $10.4 million in its second quarter. The nutritional supplement maker posted revenue of $212.9 million in the period. USANA Health expects full-year earnings to be $2.40 to $1.55 per share.
Barchart · 2d ago
Weekly Report: what happened at USNA last week (0715-0719)?
Weekly Report · 3d ago
RSPS: Consumer Staples Dashboard For July
monthly article series shows a dashboard with aggregate industry metrics in consumer staples. Household products are the most undervalued subsector, while the tobacco industry has a very bad quality score. The Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) calculates the median value of five fundamental ratios for each industry.
Seeking Alpha · 5d ago
There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding
USANA Health Sciences, Inc. (NYSE:USNA) has a 14.5x P/E ratio. The company's earnings have shrunk 47% in the last three years. It is trading at a lower price-to-earnings ratio than most companies in the U.S. The last year of earnings for the company is expected to be lower than the market.
Simply Wall St · 07/17 13:26
284 USANA-Sponsored Athletes in 2024 Summer Olympic and Paralympic Games
Sponsored athletes to represent 10 nations across multiple disciplines in Paris. The 284 sponsored USANA Athletes will compete at the 2024 Summer Olympic and Paralympic Games. The athletes represent Canada, China, France, Indonesia, Mexico, South Korea, Spain, and the United States.
PR Newswire · 07/17 12:08
More
Webull provides a variety of real-time USNA stock news. You can receive the latest news about Usana Health Sciences Inc through multiple platforms. This information may help you make smarter investment decisions.
About USNA
USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. The Company operates through one segment: Direct-selling. Its two geographic regions include Asia Pacific, and Americas and Europe. The Company’s product lines include USANA Nutritionals Optimizers, Essentials/CellSentials, foods, personal care, skin care, and all others. The USANA Nutritionals Optimizers consist of supplements designed to meet individual health and nutritional needs. The Essentials/CellSentials product line includes vitamin and mineral supplements that provide total body nutrition. Its food product line includes meal replacement shakes, snack bars, and other related products. It also offers products designed for prenatal, infant, and young-child age groups in China. It distributes products internationally through direct selling, which entails person-to-person marketing and selling of products.